#RSV can be extremely dangerous for those 60 years and older. Find out how to get involved in research looking to advance prevention options.
If you are age 60 or older and in good or stable health, you may qualify for an RSV (Respiratory Syncytial Virus) Vaccine Study at Headlands Research Scottsdale. Compensation may be available for qualified participants.
RSV is a cause of serious respiratory infections in adults aged 60 and older and immunocompromised people. RSV infects about 5% to 10% of residents in long-term facilities each year, and can lead to pneumonia, and rarely, death. Learn more about this research study of an investigational vaccine intended to prevent RSV.
Respiratory syncytial virus (RSV) hospitalizes about 58,000 children and 177,000 seniors in the U.S. each year. Many areas across the U.S. are experiencing RSV outbreaks. Help fight this dangerous virus by joining an RSV vaccine study at Headlands Research Scottsdale. If eligible, you could receive compensation. Health insurance is not needed to join.
Respiratory Syncytial Virus is common, highly contagious, and may be dangerous for seniors. Vaccine studies could help. Local research studies enrolling adults 60+ now. Qualified volunteers may receive no-cost study-related care.